The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DB-1311/BNT324 (a novel B7H3 ADC) in patients with heavily pretreated castrate-resistant prostate cancer (CRPC).
 
Andrew Parsonson
Research Funding - BeiGene (Inst); DualityBio (Inst); Innovent Biologics (Inst); Jiangsu Hengrui Medicine (Inst); Multitude Therapeutics (Inst)
 
Chintan Gandhi
No Relationships to Disclose
 
Brian Henick
Honoraria - DAVA Oncology; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; IDEAYA Biosciences; Jazz Pharmaceuticals; Regeneron; Sorrento Therapeutics; Synthekine
Research Funding - Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst); NexImmune (Inst); Stand Up 2 Cancer (Inst); V Foundation (Inst)
 
Andrew Schmidt
Employment - BeiGene (I)
Stock and Other Ownership Interests - BeiGene (I)
Consulting or Advisory Role - Astellas Pharma; bms; MSD
Travel, Accommodations, Expenses - MSD
 
Dingwei Ye
No Relationships to Disclose
 
Harshad Amin
No Relationships to Disclose
 
Trisha Wise-Draper
Stock and Other Ownership Interests - High Enroll
Consulting or Advisory Role - Adaptimmune; Adlai Nortye; Caris Life Sciences; EMD Serono; Genmab; Merck; Need; Replimune
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Caris Life Sciences
 
Kevin Courtney
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene/Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Myovant Sciences (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Surface Oncology (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Laura Tam
No Relationships to Disclose
 
Shusuan Jiang
No Relationships to Disclose
 
Theodore Gourdin
Consulting or Advisory Role - Pfizer; Sanofi
Research Funding - Ferring (Inst)
 
Aaron Lisberg
Employment - Boston Scientific (I)
Stock and Other Ownership Interests - Boston Scientific (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Nordics; G1 Therapeutics; Gilead Sciences; IQVIA; Janssen Oncology; Jazz Pharmaceuticals; Leica Biosystems; Lilly; Molecular Axiom; MorphoSys; Novartis; Novocure; Oncocyte; Pfizer; Sanofi; Sanofi/Regeneron
Research Funding - AstraZeneca; Calithera Biosciences; Daiichi Sankyo; Dracen; Duality Biologics; eFFECTOR Therapeutics; WindMIL
Patents, Royalties, Other Intellectual Property - Pending Patents U.S. Provisional Patent Application No. 63/527,899
 
Raoul Tibes
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
 
Jenny Furlanetto
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
 
Lianghua Fang
Employment - Duality Biologics
 
Yang Qiu
Employment - Duality Biologics
Leadership - Duality Biologics
Stock and Other Ownership Interests - Duality Biologics
 
Rong Shi
Employment - Duality Biologics
 
Jiawei Wei
Employment - Duality Biologics
 
Bin Zhang
Employment - Duality Biologics
 
Mark Stein
Stock and Other Ownership Interests - Rafael Holdings
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Bristol-Myers Squibb/Medarex; Exelixis; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Regeneron (Inst); Repare Therapeutics (Inst); Vaccitech; Xencor
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals; Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Regeneron (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)